Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin La
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
What it found
Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.
What was tested
Treatment tested
- Magnetic Resonance Imaging
Results by group
Regional Cerebral Blood Flow Values of the Brain Measured Using Pseudo-continuous Arterial Spin Labeling (pCASL) MRI.
single encounter
| Group | Value | Interval | Number analysed |
|---|---|---|---|
| Magentic Resonance Imaging | 35.4 ml/100g/min | 5.7 (Standard Deviation) | 1 |
Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.
Safety
| Group | Participants at risk | Serious adverse events | Deaths |
|---|---|---|---|
| Magentic Resonance Imaging | 1 | 0 (0.0%) | 0 |
As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.
What it measured
Main measures
Regional Cerebral Blood Flow Values of the Brain Measured Using Pseudo-continuous Arterial Spin Labeling (pCASL) MRI.
single encounter
MRI lesions
Who could take part
MS (type not specified) · 18 to 90
Show the full criteria
Inclusion criteria
* Any person between the ages of 18-90 years, who is undergoing routine magnetic resonance imaging (MRI) of the head with or without contrast at Loma Linda University Medical Center. * Must be eligible for MRI (no electronic or metal implants that are not MR compatible).
Exclusion criteria
* Electronic or metal implant that is not MRI safe, pregnancy or claustrophobia.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study will test a new MRI sequence that measures cerebral blood flow (CBF). Because this technique for measuring CBF is new, there is little information on what the normal values for different regions of the brain should be. Information from the study will be used to establish normative CBF values for the brain, improving the reliable use of this technique for the diagnosis of brain injury or disease.
Loading reviews and guidelines…
History
Started
May 2014
Main results due
Mar 2017
Finished
Mar 2017
Results posted
Apr 2019